SHR-2004, a Humanized Monoclonal Antibody Targeting Factor XI, for Preventing Venous Thromboembolism After Ovarian Cancer Surgery: A Randomized, Active-Controlled Phase 2 Study
用户9_B5Dy7pMe4M
57分钟前
8
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-09-22 09:47:21 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

